- Previous close
6.35 - Open
6.51 - Bid --
- Ask --
- Day's range
6.32 - 6.51 - 52-week range
4.14 - 9.26 - Volume
123,902 - Avg. Volume
1,294,131 - Market cap (intra-day)
2.434B - Beta (5Y monthly) 1.38
- PE ratio (TTM)
-- - EPS (TTM)
-0.14 - Earnings date 7 Nov 2024
- Forward dividend & yield --
- Ex-dividend date --
- 1y target est
9.44
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
www.goodrx.com694
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Health Information Services
Industry
Recent news: GDRX
View more
Performance overview: GDRX
Trailing total returns as of 29/10/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: GDRX
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: GDRX
View moreValuation measures
Market cap
2.41B
Enterprise value
2.59B
Trailing P/E
--
Forward P/E
16.10
PEG ratio (5-yr expected)
--
Price/sales (ttm)
3.28
Price/book (mrq)
3.60
Enterprise value/revenue
3.35
Enterprise value/EBITDA
23.80
Financial highlights
Profitability and income statement
Profit margin
-7.57%
Return on assets (ttm)
1.88%
Return on equity (ttm)
-7.50%
Revenue (ttm)
775.09M
Net income avi to common (ttm)
-58.68M
Diluted EPS (ttm)
-0.14
Balance sheet and cash flow
Total cash (mrq)
524.9M
Total debt/equity (mrq)
105.67%
Levered free cash flow (ttm)
56.82M